|
|
Volumn 9, Issue 11, 2012, Pages 613-614
|
|
Enzalutamide in metastatic CRPC-old dog, new tricks
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABIRATERONE ACETATE;
ANDROGEN;
ANDROGEN RECEPTOR;
CORTICOSTEROID;
DOCETAXEL;
ENZALUTAMIDE;
GONADORELIN AGONIST;
KETOCONAZOLE;
PLACEBO;
PROSTATE SPECIFIC ANTIGEN;
STEROID;
DRUG DERIVATIVE;
PHENYLTHIOHYDANTOIN;
ARTICLE;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CANCER CONTROL;
CANCER MORTALITY;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CASTRATION RESISTANT PROSTATE CANCER;
DIARRHEA;
DRUG APPROVAL;
DRUG DOSE ESCALATION;
DRUG EFFICACY;
DRUG INDUCED HEADACHE;
DRUG MECHANISM;
DRUG MEGADOSE;
DRUG SAFETY;
DRUG TARGETING;
DRUG WITHDRAWAL;
FATIGUE;
HOT FLUSH;
HUMAN;
METASTASIS POTENTIAL;
MORBIDITY;
MUSCULOSKELETAL PAIN;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
RISK REDUCTION;
SEIZURE;
SIGNAL TRANSDUCTION;
SURVIVAL TIME;
TREATMENT RESPONSE;
ANIMAL;
CASTRATION;
DISEASE RESISTANCE;
DRUG EFFECT;
MALE;
METASTASIS;
NOTE;
PROSTATE TUMOR;
ANIMALS;
CASTRATION;
DISEASE RESISTANCE;
HUMANS;
MALE;
PHENYLTHIOHYDANTOIN;
PROSTATIC NEOPLASMS;
|
|
EID: 84868190921
PISSN: 17594774
EISSN: 17594782
Source Type: Journal
DOI: 10.1038/nrclinonc.2012.181 Document Type: Article |
|
Times cited : (1)
|
|
References (10)
|
